Prescriber  	Prescriber  	 JJ	B-NP
continuity  	continuity  	 NN	I-NP
and  	and  	 CC	O
medication  	medication  	 NN	B-NP
adherence  	adherence  	 NN	I-NP
for  	for  	 IN	O
complex  	complex  	 JJ	O
patients  	patients  	 NNS	O
Medication  	Medication  	 JJ	B-NP
adherence  	adherence  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
critical  	critical  	 JJ	B-NP
aspect  	aspect  	 NN	I-NP
of  	of  	 IN	O
managing  	managing  	 VBG	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	B-NP
diabetes 	diabetes 	 NN	I-NP
,  	,  	 ,	O
hypertension 	hypertension 	 NN	O
,  	,  	 ,	O
dyslipidemia 	dyslipidemia 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
heart  	heart  	 NN	B-NP
failure 	failure 	 NN	I-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
who  	who  	 WP	O
have  	have  	 VBP	O
multiple  	multiple  	 JJ	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
and  	and  	 CC	O
multiple  	multiple  	 JJ	O
prescribers  	prescribers  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
at  	at  	 IN	O
increased  	increased  	 JJ	O
risk  	risk  	 NN	O
for  	for  	 IN	O
nonadherence 	nonadherence 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
purpose  	purpose  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
examine  	examine  	 VB	O
the  	the  	 DT	O
relationship  	relationship  	 NN	B-NP
between  	between  	 IN	O
number  	number  	 NN	O
of  	of  	 IN	O
prescribers 	prescribers 	 NN	B-NP
,  	,  	 ,	O
number  	number  	 NN	O
of  	of  	 IN	O
conditions 	conditions 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
refill  	refill  	 JJ	O
adherence  	adherence  	 NN	O
to  	to  	 TO	O
oral  	oral  	 JJ	B-NP
medications  	medications  	 NN	I-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
retrospective  	retrospective  	 JJ	B-NP
cohort  	cohort  	 JJ	I-NP
study 	study 	 NN	I-NP
,  	,  	 ,	O
7933  	7933  	 CD	O
veterans  	veterans  	 NNS	O
were  	were  	 VBD	O
identified  	identified  	 VBN	O
with  	with  	 IN	O
1  	1  	 CD	O
to  	to  	 TO	O
4  	4  	 CD	O
cardiometabolic  	cardiometabolic  	 CD	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
Refill  	Refill  	 JJ	O
adherence  	adherence  	 NN	O
to  	to  	 TO	O
oral  	oral  	 JJ	B-NP
medications  	medications  	 NN	I-NP
for  	for  	 IN	O
diabetes 	diabetes 	 NN	O
,  	,  	 ,	O
hypertension 	hypertension 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
dyslipidemia  	dyslipidemia  	 NNS	B-NP
was  	was  	 VBD	O
measured  	measured  	 VBN	O
using  	using  	 VBG	O
an  	an  	 DT	O
administrative  	administrative  	 JJ	O
claims-based  	claims-based  	 JJ	O
continuous  	continuous  	 JJ	B-NP
multiple-interval  	multiple-interval  	 JJ	I-NP
gap  	gap  	 NN	I-NP
( 	( 	 -LRB-	O
CMG 	CMG 	 NNP	B-NP
)  	)  	 -RRB-	O
that  	that  	 WDT	O
estimates  	estimates  	 VBZ	O
the  	the  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
days  	days  	 NNS	O
a  	a  	 DT	O
patient  	patient  	 NN	O
did  	did  	 VBD	O
not  	not  	 RB	O
possess  	possess  	 VB	O
medication 	medication 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
dichotomized  	dichotomized  	 VBP	B-NP
refill  	refill  	 JJ	I-NP
adherence  	adherence  	 NN	I-NP
for  	for  	 IN	O
each  	each  	 DT	O
condition  	condition  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
CMG  	CMG  	 NNP	B-NP
≤20 	≤20 	 NNP	O
%  	%  	 NN	O
for  	for  	 IN	O
each  	each  	 DT	O
year  	year  	 NN	O
of  	of  	 IN	O
analysis 	analysis 	 NN	O
.  	.  	 .	O
Condition-specific  	Condition-specific  	 JJ	B-NP
logistic  	logistic  	 JJ	I-NP
regression  	regression  	 JJ	I-NP
models  	models  	 NNS	I-NP
estimated  	estimated  	 VBD	O
the  	the  	 DT	O
relationship  	relationship  	 NN	B-NP
between  	between  	 IN	O
refill  	refill  	 JJ	O
adherence  	adherence  	 NN	O
and  	and  	 CC	O
number  	number  	 NN	O
of  	of  	 IN	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
and  	and  	 CC	O
number  	number  	 NN	O
of  	of  	 IN	O
prescribers 	prescribers 	 NN	B-NP
,  	,  	 ,	O
controlling  	controlling  	 VBG	O
for  	for  	 IN	O
demographic  	demographic  	 JJ	B-NP
characteristics 	characteristics 	 NNS	I-NP
,  	,  	 ,	O
other  	other  	 JJ	O
comorbidities 	comorbidities 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
count  	count  	 NN	O
of  	of  	 IN	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
drug  	drug  	 NN	I-NP
classes  	classes  	 NNS	I-NP
used 	used 	 VBN	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
with  	with  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
1  	1  	 CD	O
prescriber 	prescriber 	 NN	B-NP
,  	,  	 ,	O
antihypertensive  	antihypertensive  	 JJ	B-NP
refill  	refill  	 JJ	I-NP
adherence  	adherence  	 NN	I-NP
was  	was  	 VBD	O
lower  	lower  	 JJR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
seeing  	seeing  	 VBG	O
≥4  	≥4  	 CD	O
prescribers  	prescribers  	 NNS	B-NP
( 	( 	 -LRB-	O
odds  	odds  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
[ 	[ 	 -LRB-	O
OR 	OR 	 NNP	B-NP
]  	]  	 -RRB-	O
=  	=  	 SYM	O
0.69 	0.69 	 CD	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI  	CI  	 NNP	O
=  	=  	 SYM	O
0.59-0.80 	0.59-0.80 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
predictor 	predictor 	 NN	O
.  	.  	 .	O
Antidyslipidemia  	Antidyslipidemia  	 JJ	B-NP
refill  	refill  	 JJ	I-NP
adherence  	adherence  	 NN	I-NP
was  	was  	 VBD	O
lower  	lower  	 JJR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
seeing  	seeing  	 VBG	O
3  	3  	 CD	O
prescribers  	prescribers  	 NNS	B-NP
( 	( 	 -LRB-	O
OR  	OR  	 NNP	O
=  	=  	 SYM	O
0.80 	0.80 	 CD	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI  	CI  	 NNP	O
=  	=  	 SYM	O
0.70-0.92 	0.70-0.92 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
≥4  	≥4  	 CD	O
prescribers  	prescribers  	 NNS	B-NP
( 	( 	 -LRB-	O
OR  	OR  	 NNP	O
=  	=  	 SYM	O
0.77 	0.77 	 CD	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI  	CI  	 NNP	O
=  	=  	 SYM	O
0.64-0.91 	0.64-0.91 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Conversely 	Conversely 	 RB	O
,  	,  	 ,	O
antidyslipidemia  	antidyslipidemia  	 JJ	B-NP
refill  	refill  	 NNS	I-NP
adherence  	adherence  	 VBP	I-NP
improved  	improved  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
cardiometabolic  	cardiometabolic  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
differences  	differences  	 NNS	O
were  	were  	 VBD	O
only  	only  	 RB	O
statistically  	statistically  	 RB	O
significant  	significant  	 JJ	O
for  	for  	 IN	O
≥3  	≥3  	 CD	O
conditions  	conditions  	 NNS	O
( 	( 	 -LRB-	O
OR  	OR  	 NNP	O
=  	=  	 SYM	O
1.31 	1.31 	 CD	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI  	CI  	 NNP	O
=  	=  	 SYM	O
1.09-1.57 	1.09-1.57 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
multivariate  	multivariate  	 JJ	B-NP
regression  	regression  	 JJ	I-NP
models 	models 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
conditions  	conditions  	 NNS	O
and  	and  	 CC	O
number  	number  	 NN	O
of  	of  	 IN	O
prescribers  	prescribers  	 NN	B-NP
were  	were  	 VBD	O
not  	not  	 RB	O
significant  	significant  	 JJ	O
predictors  	predictors  	 NN	O
of  	of  	 IN	O
refill  	refill  	 JJ	O
adherence  	adherence  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
diabetes 	diabetes 	 NN	O
.  	.  	 .	O
Effective  	Effective  	 JJ	B-NP
management  	management  	 NN	I-NP
of  	of  	 IN	O
care  	care  	 NN	O
and  	and  	 CC	O
medication  	medication  	 NN	B-NP
regimens  	regimens  	 NN	I-NP
for  	for  	 IN	O
complex  	complex  	 JJ	O
patients  	patients  	 NNS	O
remains  	remains  	 VBZ	O
an  	an  	 DT	O
unresolved  	unresolved  	 JJ	O
challenge 	challenge 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
these  	these  	 DT	O
results  	results  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 DT	O
medication  	medication  	 NN	B-NP
refill  	refill  	 NN	I-NP
adherence  	adherence  	 NNS	I-NP
might  	might  	 MD	O
be  	be  	 VB	O
improved  	improved  	 VBN	O
by  	by  	 IN	O
minimizing  	minimizing  	 VBG	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
prescribers  	prescribers  	 VBG	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
patient 	patient 	 NN	O
's  	's  	 POS	O
care 	care 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
for  	for  	 IN	O
hypertension  	hypertension  	 NN	O
and  	and  	 CC	O
dyslipidemia 	dyslipidemia 	 NN	B-NP
.  	.  	 .	O
